A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors

Allergy Asthma Proc. 2022 Nov 1;43(6):471-473. doi: 10.2500/aap.2022.43.220081.
No abstract available

MeSH terms

  • Biological Products* / therapeutic use
  • Chronic Urticaria*
  • Dermatitis, Atopic* / drug therapy
  • Eosinophilia* / drug therapy
  • Humans
  • Janus Kinase Inhibitors* / therapeutic use
  • Lung Diseases*
  • Urticaria* / drug therapy

Substances

  • Janus Kinase Inhibitors
  • Biological Products